Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026)
Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML · Peer-reviewed
What this source contributed
Records in this release that cite this source. A record can cite several sources.
Results
Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.
Claims
Statements this source supports, each with where in the source it was checked.
- Baseline: Select a copy-number variant detection and characterisation workflow: Baseline ExomeDepth, CNVnator, AnnotSV and ClassifyCNV (cnv-20261009-source-gabrielaite2021: Abstract and Results (callers compared and recommended); cnv-20261011-hwang2026-source-article: Abstract and Materials and Methods 2.3 (ExomeDepth among four WES callers); cnv-20261011-zhang2026-source-article: Methods (rule-based and machine-learning tool categories))
- Evidence summary: Select a copy-number variant detection and characterisation workflow: Summary On HG002 deletions, DRAGEN 4.2 with SV-informed CNV calling found 87 to 100% of deletions in every size bin, with precision 0.99 to 1.00; this is the developers' own benchmark. CNVnator matched it above 10 kb but found only 26% of deletions of 1 to 5 kb and 51% of 5 to 10 kb. On NA12878, LUMPY, DELLY and Manta recovered 88 to 94% of known CNVs, but only 20 to 33% of their calls matched; Manta and CNVnator were used to build this truth set, which can favour them. The other callers recovered 1 to 43%. Hwang et al. (2026) compared four exome callers with chromosomal microarray CNVs in 39 clinical exomes, scoring deletion and duplication exons together: sensitivity and PPV were 0.758 and 0.025 for ExomeDepth, 0.662 and 0.096 for CNVkit, 0.768 and 0.239 for CoNIFER and 0.170 and 0.041 for cn.MOPS. The truth set keeps only array CNVs with at least ten probes that overlap exome baits, so any other exon call counts as a false positive. After the authors removed regions where each tool called CNVs in more than 10% of the same 180-exome cohort, ExomeDepth reached 0.903 and 0.102 on a smaller reference set of 2,124 exons (Table 4); this filter is the authors' own method. For characterisation, Zhang et al. (2026) ran five automated ACMG classifiers on 3,031 expert-classified CNVs: five-category accuracy, averaged across classes in a way the paper does not state, ranged from 48.76% (X-CNV) to 69.81% (MarCNV-ISV) (Table 3). With likely and definite classes merged, every tool recognised more pathogenic deletions than pathogenic duplications (AnnotSV 95.16% versus 86.39%) (Table 4). Two of the three authors developed dbCNV and the reference includes their own laboratory's cases, so the dbCNV results are author-reported. None of the comparisons shown reports duplication detection separately, none covers tumour samples or long reads, and none evaluates a foundation model. (amp-source-dragen-supplementary-tables: sheet 'S4 CNV benchmarking' rows 6-10; cnv-20261009-source-gabrielaite2021-table-s2: rows with sample GB-WGS-NA12878; cnv-20261011-hwang2026-source-article: Table 4; Methods 2.2 and 2.5; cnv-20261011-zhang2026-source-article: Tables 3 and 4)
- Relevance of ACMG five-category CNV pathogenicity classification against expert labels (Zhang et al. Table 3) to "Select a copy-number variant detection and characterisation workflow": Assessed by ACMG five-category CNV pathogenicity classification against expert labels (Zhang et al. Table 3) (cnv-20261011-zhang2026-source-article: Table 3; Methods 'Data analysis'; Results 'Comparative analysis of clinical metrics')
- Relevance of Three-category CNV classification, per-class agreement on deletions (Zhang et al. Table 4, DEL) to "Select a copy-number variant detection and characterisation workflow": Assessed by Three-category CNV classification, per-class agreement on deletions (Zhang et al. Table 4, DEL) (cnv-20261011-zhang2026-source-article: Table 4 rows 'DEL' B, VUS, P; Results 'Analysis of three-category performance')
- Relevance of Three-category CNV classification, per-class agreement on duplications (Zhang et al. Table 4, DUP) to "Select a copy-number variant detection and characterisation workflow": Assessed by Three-category CNV classification, per-class agreement on duplications (Zhang et al. Table 4, DUP) (cnv-20261011-zhang2026-source-article: Table 4 rows 'DUP' B, VUS, P; Results 'Analysis of three-category performance')
Models, benchmarks and other records
Methods (5)
Configurations (5)
Protocols (3)
Datasets (1)
Evaluations (15)
- AnnotSV on the expert-classified ACMG CNV benchmark (five category)
- AnnotSV on the expert-classified ACMG CNV benchmark (three category deletions)
- AnnotSV on the expert-classified ACMG CNV benchmark (three category duplications)
- ClassifyCNV on the expert-classified ACMG CNV benchmark (five category)
- ClassifyCNV on the expert-classified ACMG CNV benchmark (three category deletions)
- ClassifyCNV on the expert-classified ACMG CNV benchmark (three category duplications)
- dbCNV on the expert-classified ACMG CNV benchmark (five category)
- dbCNV on the expert-classified ACMG CNV benchmark (three category deletions)
- dbCNV on the expert-classified ACMG CNV benchmark (three category duplications)
- MarCNV-ISV on the expert-classified ACMG CNV benchmark (five category)
- MarCNV-ISV on the expert-classified ACMG CNV benchmark (three category deletions)
- MarCNV-ISV on the expert-classified ACMG CNV benchmark (three category duplications)
- X-CNV on the expert-classified ACMG CNV benchmark (five category)
- X-CNV on the expert-classified ACMG CNV benchmark (three category deletions)
- X-CNV on the expert-classified ACMG CNV benchmark (three category duplications)
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
18 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Artifact SHA-256 a0810a8bff1ab3d2603a4832a56291cc182c8530aa8dffc6ac5318abd989ada0 Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Artifact url https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13018948/fullTextXML Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Doi 10.1016/j.gmg.2026.100096 Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Licence CC-BY-NC-ND-4.0 Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations6 values
| Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Media type application/xml Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Publication status peer_reviewed Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Retrieved at 2026-10-11T21:36:59Z Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Url https://doi.org/10.1016/j.gmg.2026.100096 Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Version Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML Source metadata | Can automated copy number variation pathogenicity prediction tools replace manual review under the ACMG framework? A clinical validation (Zhang, Zhang and Chen, Global Medical Genetics 2026) No field-specific location recorded Version: Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML | catalogued No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-02-a7f03c9e55a5 · Record review: source checked
Primary source retrieved and hashed for the 2026-10-11 use-case literature pass.
Technical metadata and extraction receipts
Stable ID: cnv-20261011-zhang2026-source-article
- areas
- dna-genomes
- contexts
- clinical_research
- url
- https://doi.org/10.1016/j.gmg.2026.100096
- artifact url
- https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13018948/fullTextXML
- version
- Global Medical Genetics 13:100096 (2026), published online 2026-03-06; PMC13018948 full-text XML
- retrieved at
- 2026-10-11T21:36:59Z
- artifact sha256
- a0810a8bff1ab3d2603a4832a56291cc182c8530aa8dffc6ac5318abd989ada0
- doi
- 10.1016/j.gmg.2026.100096
- publication status
- peer_reviewed
- licence
- CC-BY-NC-ND-4.0
- media type
- application/xml
- limitations
- Methods 'Data analysis' list AUC-ROC, specificity, sensitivity, PPV, FPR and F1 but do not say how the five-category results in Table 3 are averaged across classes.; Supplementary Table S1 (MarCNV-ISV conservative and progressive modes) was not retrieved.; The benchmark dataset is not public ('available from the corresponding author on reasonable request').; Not archived in the batch: CC BY-NC-ND licence; hash and locators only.; The Abstract gives ClassifyCNV VUS accuracy 95.33%; Table 4 prints 94.92% (duplications) and 95.74% (deletions), which with the Table 2 class sizes (886 and 329) pool to about 95.1%.; Two Table 4 deletion cells are not a whole-number share of the Table 2 class size (AnnotSV P 95.16% of 287 P and LP deletions; MarCNV-ISV VUS 89.86% of 329 VUS deletions); the other 28 cells are.